



- Stock: In Stock
- Model: 177019
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Verrukutan solution nakozh. 5mg/g +100mg/g fl. 13 ml
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
Verrukutan is a dermatological medicament against warts and callosities.
Indications - common warts (especially warts on sites of a foot of whom the biggest loading is the share), flat juvenile warts of extremities.
Structure
contains- 1 g of solution 5 mg of a flyuorouratsil and 100 mg of salicylic acid;
- other components: a dimethyl sulfoxide, ethanol waterless, ethyl acetate, guncotton, weed (butyl-methacrylate-to-methylmethacrylate) (80: 20).
Contraindication
Hypersensitivity to active ingredients or to any excipients.
Verrukutan should not be applied to women during feeding by a breast, to pregnancy and women whose pregnancy cannot be excluded with definiteness.
Verrukutan should not be applied to babies and patients with a renal failure.
Route of administration Usually verrukutan should applyto
from two to three times a day on each wart. The usual duration of application is 6 weeks. Means should be put regularly every day. After completion of successful therapy the treatment should be prolonged for 1 week. Feature of application
to
On skin zones with the warts having thin epidermis, means it is necessary to put more rare and the course of treatment should be controlled more often as salicylic acid as a part of Verrukutan renders powerful effect of mitigation of a corneal layer of epidermis that can cause emergence of hems.
On the warts inclined to keratinization, sometimes it is reasonable to plaster previously with salicylic acid.
Pregnant
Verrukutan should not be applied to women during pregnancy.
Children
Verrukutan should not be applied to babies.
Drivers
Verrukutan does not influence or has insignificant impact on ability to steer motor transport or other mechanisms.
Overdose
Early symptoms of salitsilatny intoxication can take place at serumal levels more than 30 mg/dl.
They are shown by a ring in ears, sonitus with decrease in hearing, nasal bleeding, nausea, vomiting, irritation and dryness of mucous.
Side effects
from nervous system: headaches.
from organs of sight: xerophthalmus, an itch in eyes, the raised slezootdeleniye.
from skin: peeling.
General violations and violations in the injection site: in the place of application: an erythema, inflammation, irritation (including burning sensation), pain, an itch.
Storage conditionsto Store
at a temperature not above 30 °C. Not to cool and not to freeze. To store out of children's reach.
Specifications
Characteristics | |
Active ingredients | Salicylic acid, Flyuorouratsil |
Amount of active ingredient | 5 mg/g + 100 mg/g |
Applicant | Mibe |
Code of automatic telephone exchange | The Means D11AF applied to removal of warts and callosities |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | Traditional |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | bottle |
Producer | IIB OF GMBH ARTSNAYMITTEL |
Quantity in packing | 1 bottle |
Release form | solution for external use |
Route of administration | External |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Verrukutan |